XTL Biopharmaceuticals Ltd.

Regulatory Filings • Jun 12, 2008

_________ false

C007��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996428Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 12/06/2008              Time of broadcast: 10:25 10:24:05

Reference: 2008-02-165240

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 17/07/2008 at 16:30 the corporation will hold it's special meetingat at Building 3, Kiryat Weizmann Science Park, Rehovot, PO Box 370, Israel 76100

According to section 182 C of the Companies law, 5759-1999, only shareholders of record at the close of business 02/06/2008 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report AGMEGM170708_isa.pdf

Attached hereto is the proxy statement ProxyAGMEGM170708_isa.pdf

The attached documents relates also to the company's Annual General meeting to be held at the same date and place at 16:00.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 30/04/2008
- - -
Name of the Signatory: : Kantor Ronen , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary , Name of Employer Company: .
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2